| 1. |
2025
Ho HL,Lin SC,Chiang CW, Lin C, Liu CW,Yeh YC, Chen MY, Chou TY..
miR-193b-3p suppresses lung cancer cell migration and invasion through PRNP targeting.
. Journal of Biomedical Science
.2025
|
|
| 2. |
2024
Chou TY,Dacic S,Wistuba I,Mary Beth Beasley,Sabina Berezowska,「Yeun-Chung Chang, Jin-Haeng Chung,et al.」.
Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee.
. Journal of Thoracic Oncology
.2024
|
|
| 3. |
2024
Chiu YJ,Li CY,Wang TH,Ma H,Chou TY.
Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals.
. J Dermatol
.2024
|
|
| 4. |
2023
Chiang CL ,Ho HL,Yeh YC,Lee CC,Huang HC,Shen CI, Luo YH, Chen YM, Chiu CH, Chou TY.
Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases.
. Thoracic Cancer
.2023
|
|
| 5. |
2023
Yang CY,Yeh YC,Wang LC,Lin YY,Lin SY,「Wang SY, Chu PY, Liu ZY, Su YC, Ho HL, Chou TY」.
Genomic profiling with large scale next generation sequencing panels distinguishes separate primary lung adenocarcinomas from intrapulmonary metastases.
. Mod Pathol
.2023
|
|
| 6. |
2023
Lei-Chi Wang,Yu-Han Hsieh,Yu-Ling Hung,Yu-Ting Jiang,Yu-Chieh Lin,「Margaret Dah-Tsyr Chang, Yen-Yin Lin」.
Panoramic Tissue Examination That Integrates 3-Dimensional Pathology Imaging and Gene Mutation: Potential Utility in NoneSmall Cell Lung Cancer.
. Lab Invest
.2023
|
|
| 7. |
2022
Lin YY, ,,Wang LC, ,Hsieh YH, ,Hung YL,, Chen YA, ,「Yu‑Chieh Lin3,4, Yen‑Yin Lin3 and Teh‑Ying Chou」.
Computer-assisted three-dimensional quantitation of programmed death-ligand 1 in non-small cell lung cancer using tissue clearing technology.
. Journal of Translational Medicine
.2022
|
|
| 8. |
2022
Ho HL,Wang FY,Chiang CL,Tsai CM,Chiu CH,Chou TY.
Dynamic Assessment of Tissue and Plasma EGFR-Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs.
. International Journal of Molecular Science
.2022
|
|
| 9. |
2022
hang WC, ,Yeh YC, ,Ho HL, ,Chou TY.
Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome.
. Human Pathology
.2022
|
|
| 10. |
2022
Lin CH, ,Liao CC,Wang SY,Peng CY,Yeh YC,Chen MY, Chou TY.
Comparative O-GlcNAc Proteomic Analysis Reveals a Role of O-GlcNAcylated SAM68 in Lung Cancer Aggressiveness.
. Cancers
.2022
|
|
| 11. |
2022
Chiang CL,Ho HL,Yeh YC,Lee CC,Huang HC,「 Shen CI, Luo YH, Chen YM, Chiu CH, Chou TY」.
Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis.
. J Cancer Res Clin Oncol.,
.2022
|
|
| 12. |
2022
Chiu YJ,Weng HY,Lin YY,Lin YF,Yeh YC,「Perng CK, Ma H, Tsai SF, Chou TY」.
Genomic profiling with whole-exome sequencing revealed distinct mutations and novel pathways in Asian melanoma.
. J Dermatol.,
.2022
|
|
| 13. |
2022
Ho HL,Wang FY,Chiang CL, Tsai CM,Chiu CH,Chou TY.
Dynamic Assessment of Tissue and Plasma EGFR-Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs.
. Int J Mol Sci
.2022
|
|
| 14. |
2022
Peng YC,Lin YC,Hung YL, Fu CC,Chang MD,「Lin YY, Chou TY」.
Rapid Histological Assessment of Prostate Specimens in the Three-dimensional Space by Hydrophilic Tissue Clearing and Confocal Microscopy.
. J Histochem Cytochem
.2022
|
|
| 15. |
2022
Ho HL,Jiang Y,Chiang CL,Karwowska S,Yerram R,Sharma K「Scudder S,Chiu CH, Tsai CM, Palma JF, Sharma A, Chou TY*」.
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer. PLoS One. 2022 Apr 28;17(4):e0267362.
. PLoS One
.2022
|
|
| 16. |
2022
Yeh YC, Ma HH,Chu PY,Ho HL,Chou TY.
Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer.
. JTO Clinical Research Report
.2022
|
|
| 17. |
2021
Lee CY,Wu TH, Fang YP,Chang JC,Wang HC,「Lin SJ, Mai CH, Chang YC, Chou TY」.
Delayed respiratory syncytial virus outbreak in 2020 in Taiwan was correlated with two novel RSV-A genotype ON1 variants.
. Influenza and Other Respiratory Viruses
.2021
|
|
| 18. |
2021
Lin YY,Wang YC,Yeh DW,Hung CY,Yeh YC,「Ho HL, Mon HC, Chen MY, Wu YC」.
Gene Expression Profile in Primary Tumor Is Associated with Brain-Tropism of Metastasis from Lung Adenocarcinoma.
. International journal of molecular sciences
.2021
|
|
| 19. |
2021
Lin CH,Liao CC,Chen MY.
Feedback Regulation of OGlcNAc Transferase through Translation Control to Maintain Intracellular OGlcNAc Homeostasis.
. International Journal of Molecular Sciences
.2021
|
|
| 20. |
2020
Ho HL,Wang FY,Lee HR,Huang YL,Lai CL,Jen WC「Hsieh SL,Chou TY*」.
Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients. The Lancet Regional Health-Western Pacific, 3:100041.
. Lancet Regional Health-Western Pacific
.2020
|
|
| 21. |
2020
Yeh YC,Ho HL,Wu YC,Pan CC,Wang YC, Chou TY.*.
AKT1 internal tandem duplications and point mutations are the genetic hallmarks of sclerosing pneumocytoma. Mod Pathol. (2020) Mar;33(3):391-403. (5-year IF: 8.048; Rank: PATHOLOGY 6/77, 7.79%)
. MODERN PATHOLOGY
.2020
|
|
| 22. |
2020
Lin SC,Lin CH,Shih NC,Liu HL,Wang WC,Lin KY「Liu ZY, Tseng YJ, Chang HK, Lin YC, Yeh YC, Minato H, Fujii T, Wu YC, Chen MY, Chou TY.*」.
Cellular prion protein transcriptionally regulated by NFIL3 enhances lung cancer cell lamellipodium formation and migration through JNK signaling. Oncogene. (2020) Jan;39(2):385-398. (5-year IF: 9.273; Rank: BIOCHEMISTRY & MOLECULAR BIOLOGY 40/296, 13.51%)
. ONCOGENE
.2020
|
|
| 23. |
2019
Yeh YC,Kao HL,Lee KL,Wu MH,Ho HL,Chou TY*.
Epstein-Barr Virus-associated Pulmonary Carcinoma: Proposing an Alternative Term and Expanding the Histologic Spectrum of Lymphoepithelioma-like Carcinoma of the Lung. Am J Surg Pathol. (2019) Feb;43(2):211-219. (5-year IF: 7.582; Rank: PATHOLOGY 18/211, 8.53%)
. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
.2019
|
|